SCHEMBL30679616

SCHEMBL30679616

Sc1ccc(-c2ccccc2-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 1/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ BCL2L1 Q07817 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CYP2A6 P11509 1/20 0.46
▸ BACE1 P56817 1/20 0.42
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ DPP4 P27487 1/20 0.41
▸ ABL1 P00519 1/20 0.39
▸ ABCB1 P08183 1/20 0.39
▸ BCR P11274 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30170547 0.94 ABL1 (0.42) PTGS2ALDH1A1HSD17B10BCL2L1MAPK1
SCHEMBL625213 0.85 BACE1 (0.41) PTGS2ALDH1A1HSD17B10BCL2L1MAPK1
SCHEMBL12273835 0.85 BACE1 (0.41) PTGS2ALDH1A1HSD17B10BCL2L1MAPK1
SCHEMBL94499 0.85 ALDH1A1 (0.60) ALDH1A1HSD17B10BCL2L1MAPK1TDP1
Biphenyl SCHEMBL28041385 0.85 ALDH1A1 (0.60) ALDH1A1HSD17B10BCL2L1MAPK1TDP1
SCHEMBL12696283 0.85 ALDH1A1 (0.60) ALDH1A1HSD17B10BCL2L1MAPK1TDP1
SCHEMBL966905 0.85 ALDH1A1 (0.60) ALDH1A1HSD17B10BCL2L1MAPK1TDP1
Benzenethiol SCHEMBL3902726 0.84 KMT2A (0.39) PTGS2ALDH1A1HSD17B10BCL2L1MAPK1
SCHEMBL17415646 0.82 ALDH1A1 (0.56) ALDH1A1HSD17B10BCL2L1MAPK1TDP1
SCHEMBL28039803 0.82 ALDH1A1 (0.56) ALDH1A1HSD17B10BCL2L1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116071-A1 METHOD OF MANUFACTURING LIQUID EJECTION HEAD, AND LIQUID EJECTION HEAD CANON KK (JP) 2026-04-30 — — US disclosed
US-20250115705-A1 RESIN COMPOSITION FOR LENS, CURED SUBSTANCE FOR LENS, AND LENS MITSUI CHEMICALS, INC. (JP) 2025-04-10 — — US disclosed
EP-4522231-A1 NITRIC OXIDE PRECURSORS AND MULTI-COMPONENT COMPOSITIONS FOR FORMING THE SAME Sterile State LLC (US) 2025-03-19 — — EP disclosed
EP-4462162-A1 RESIN COMPOSITION FOR LENS, CURED PRODUCT FOR LENS, AND LENS Mitsui Chemicals, Inc. (JP) 2024-11-13 — — EP disclosed
WO-2023219811-A1 NITRIC OXIDE PRECURSORS AND MULTI-COMPONENT COMPOSITIONS FOR FORMING THE SAME STERILE STATE, LLC (US) 2023-11-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116071-A1 METHOD OF MANUFACTURING LIQUID EJECTION HEAD, AND LIQUID EJECTION HEAD ASIC1, PTGER1, PELP1 PTGS2 443/4885ALDH1A1 586/4885HSD17B10 1840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback